Palisade Bio Inc (PALI) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.85
• Market Cap: $283.49M
• EPS: $-2.07
• 52-Week High: $2.64
• 52-Week Low: $0.53

Market Sentiment

Palisade Bio Inc currently has a Bullish sentiment score of 0.56.

About Palisade Bio Inc

Palisade Bio Inc. is a clinical-stage biopharmaceutical company headquartered in Carlsbad, California, specializing in the development of innovative therapies aimed at protecting the gastrointestinal mucosal barrier. The company's proprietary drug candidates target significant unmet medical needs in gastrointestinal disorders, reflecting a commitment to improving patient outcomes. With a robust research and development framework, Palisade Bio is strategically positioned to advance the field o...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Palisade Bio Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PALI pay dividends?

Palisade Bio Inc (PALI) does not currently pay a regular dividend.

What is PALI's market cap?

Palisade Bio Inc (PALI) has a market capitalization of $283.49M with a current stock price of $1.85.